False-positive acetylcholine receptor antibody results in patients without myasthenia gravis

Autor: Saiju Jacob, Girija Sadalage, Philip Alexander Ambrose, Angela Vincent, Paul Maddison

Publikováno v: Journal of Neuroimmunology. 332:69-72

Acetylcholine receptor antibodies are very specific for myasthenia. During a large prospective cohort study of myasthenia, we encountered five patients, positive for acetylcholine receptor (AChR) antibodies by radioimmunoprecipitation assay (RIA), wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd2c9f8176c5a219e69a98bf5940237
https://doi.org/10.1016/j.jneuroim.2019.04.001

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Autor: Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, Yingkai Li, Maria E Farrugia, Amanda C Guidon, Jinny O Tavee, Henry Kaminski, James F Howard, Gary Cutter, Heinz Wiendl, Matthew B Maas, Isabel Illa, Renato Mantegazza, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J Nowak, Alok Tyagi, Ana Paula Sousa, Anthony A Amato, Ashwin Pinto, Bhaskar Roy, Caroline Carmichael, Dubravka Dodig, Georgina Burke, Gary R Cutter, Henry J Kaminski, Ikjae Lee, Jeffrey Guptill, James F. Howard, James Caress, Jane Pritchard, John Vissing, Kamla Best, Mahtab Ramezani, Mathew Maas, Michael K Hehir, Michelle Kaku, Natalia Jiménez Esquivel, Paul Gallagher, Paul Maddison, Philip A Ambrose, Renato E Mantegazza, Rocio Vazquez Do Campo, Sami Saba, Shahriar Nafissi, Shannon Itoyama, Stuart Viegas Viegas, Victoria Marshall, Yingkai Li Li

Publikováno v: LANCET NEUROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The Lancet. Neurology
The Lancet Neurology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5728d2028ac5938c7dda87e81a9e0bc
https://doi.org/10.1016/s1474-4422(20)30413-0

A Prospective Study of the Incidence of Myasthenia Gravis in the East Midlands of England

Autor: Paul Maddison, Girija Sadalage, Angela Vincent, Philip Alexander Ambrose

Publikováno v: Neuroepidemiology. 53(1-2)

Objectives: A number of worldwide studies have highlighted a rising incidence of myasthenia gravis (MG) over the past few decades. This is largely due to an increase in numbers in older patients. To establish whether this was a consistent finding in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3a9ff9ef17070fed608bf7565f7853d
https://pubmed.ncbi.nlm.nih.gov/31067543

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis

Autor: Liis, Sabre, Paul, Maddison, Girija, Sadalage, Philip Alexander, Ambrose, Anna Rostedt, Punga

Publikováno v: Journal of neuroimmunology. 321

There are no biomarkers for late onset myasthenia gravis (LOMG; onset50 years). We evaluated circulating microRNA in a discovery cohort of 4 LOMG patients and 4 healthy controls and in a prospective diagnostic validation cohort of 73 LOMG patients (4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::87d2ba2a9f315d359f789bb9b80b9dd6
https://pubmed.ncbi.nlm.nih.gov/29804819

Reader response: Clinical Reasoning: A 56-year-old woman with acute vertigo and diplopia

Autor: Philip Alexander Ambrose

Publikováno v: Neurology. 92:248.2-248

There are wider implications of the treatments described by Sharma et al.1 Bortezomib works by promoting apoptosis in long-lived and short-lived plasma cells responsible for long-lived immunity. These cells produce background levels of vaccine-induce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96e6c8ba3455e047e563ec72f509902e
https://doi.org/10.1212/wnl.0000000000006845